E-LIB Suche - Ergebnisse für: Kucher, Klaus

1

A randomized, placebo-controlled phase 3 trial of the PI3Kδ..:

Rao, V. Koneti ; Webster, Sharon ; Šedivá, Anna...
Blood. 141 (2023) 9 - p. 971-983 , 2023

2

Intravenous immunoglobulin significantly reduces exposure o..:

Jordan, Stanley C. ; Kucher, Klaus ; Bagger, Morten...
American Journal of Transplantation. 20 (2020) 9 - p. 2581-2588 , 2020

Link: https://doi.org/10.1111/..

3

CYP3A but not P‐gp plays a relevant role in the in vivo int..:

De Buck, Stefan ; Kucher, Klaus ; Hara, Hisanori..
Biopharmaceutics & Drug Disposition. 39 (2018) 8 - p. 394-402 , 2018

Link: https://doi.org/10.1002/..

4

First-in-Man Intrathecal Application of Neurite Growth-Prom..:

Kucher, Klaus ; Johns, Donald ; Maier, Doris...
Neurorehabilitation and Neural Repair. 32 (2018) 6-7 - p. 578-589 , 2018

Link: https://doi.org/10.1177/..

5

O1‐10‐06: Results From a First‐in‐Human Study with the Bace..:

Ufer, Mike ; Rouzade-Dominguez, Marie-Laure ; Huledal, Gunilla...
Alzheimer's & Dementia. 12 (2016) 7S_Part_4 - p. , 2016

Link: https://doi.org/10.1016/..

6

Dose-dependent suppression of human photoparoxysmal respons..:

Kasteleijn-Nolst Trenité, Dorotheé ; Brandt, Christian ; Mayer, Thomas...
Epilepsia. 56 (2015) 6 - p. 924-932 , 2015

Link: https://doi.org/10.1111/..

7

AQW051, a novel, potent and selective α7 nicotinic ACh rece..:

Feuerbach, Dominik ; Pezous, Nicole ; Weiss, Markus...
British Journal of Pharmacology. 172 (2015) 5 - p. 1292-1304 , 2015

Link: https://doi.org/10.1111/..

8

Translocator Protein (18 kD) as Target for Anxiolytics with..:

Rupprecht, Rainer ; Rammes, Gerhard ; Eser, Daniela...
Science. 325 (2009) 5939 - p. 490-493 , 2009

Link: https://www.jstor.org/st..

9

Translocator Protein (18 kD) as Target for Anxiolytics With..:

Rupprecht, Rainer ; Rammes, Gerhard ; Eser, Daniela...
Science. 325 (2009) 5939 - p. 490-493 , 2009

Link: https://doi.org/10.1126/..

10

Evaluation of the CCK-4 model as a challenge paradigm in a ..:

Eser, Daniela ; Schüle, Cornelius ; Baghai, Thomas...
Psychopharmacology. 192 (2007) 4 - p. 479-487 , 2007

Link: https://doi.org/10.1007/..

11

Fibrin Formation and Proteolysis during Ancrod Treatment: E..:

DEMPFLE, CARL‐ERIK ; ARGIRIOU, SOTIRIA ; ALESCI, SONJA...
Annals of the New York Academy of Sciences. 936 (2001) 1 - p. 210-214 , 2001

Link: https://doi.org/10.1111/..

12

Plasminogen Activation Without Changes in tPA and PAI-1 in ..:

Dempfle, Carl-Erik ; Alesci, Sonja ; Kucher, Klaus...
Thrombosis Research. 104 (2001) 6 - p. 433-438 , 2001

Link: https://doi.org/10.1016/..

13

Chronopharmacology of intravenous and oral modified release..:

Dilger, Karin ; Eckhardt, Klaus ; Hofmann, Ute...
British Journal of Clinical Pharmacology. 47 (1999) 4 - p. 413-419 , 1999

Link: https://doi.org/10.1046/..

14

A randomized, placebo-controlled phase 3 trial of the PI3Kδ..:

Rao, V. Koneti ; Webster, Sharon ; Šedivá, Anna...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163280/. , 2023

Link: http://www.ncbi.nlm.nih...

15

AQW051, a novel, potent and selective α7 nicotinic ACh rece..:

Feuerbach, Dominik ; Pezous, Nicole ; Weiss, Markus...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337702/. , 2015

Link: http://www.ncbi.nlm.nih...